Company
Technology
Team
Board of Directors
Management
Extended Management
Project Management
Partners & Advisors
Preclinical Research
Clinical Research
Strategic Investment
Investors
News
Company News
Scientific Publications
Contact
28 March 2022
New Swiss COVID-19 vaccination as a nasal spray
RocketVax is developing the second-generation COVID-19 vaccine while using the live attenuated SARS-CoV-2 virus vaccine
PREVIOUS NEWS
NEXT NEWS
SHARE THIS NEWS